' fill='%23ffffff'%3E%3Cpath d='M283.94,167.31l386.39,516.64L281.5,1104h87.51l340.42-367.76L984.48,1104h297.8L874.15,558.3l361.92-390.99 h-87.51l-313.51,338.7l-253.31-338.7H283.94z M412.63,231.77h136.81l604.13,807.76h-136.81L412.63,231.77z'%3E%3C/path%3E%3C/g%3E%3C/svg%3E%0A){kind=small}
Search result
Dundee clinical trials team recognised internationally for rapid launch of Parkinson’s Disease study
Dundee’s clinical trials and research team has received international recognition after its site became one of the first in the world to launch a phase 3 clinical trial investigating a potential disease-modifying treatment for Parkinson’s disease The PARAISO study (BN44715) is investigating a monoclonal antibody designed to target abnormal protein clumps in the brain associated with Parkinson’s disease. The aim of the study is to determine whether the investi...
Speakers
Over 60 inspiring and influential speakers offer a varied programme of presentations and discussions reflecting the diversity of health research and innovation activity across Scotland. Please check back here for speaker biographies, or join our
National Contract Value Review
The national contract value review (NCVR) is a standardised, national approach to costing for commercial contract research From 14 October 2024, NCVR will include Early Phase (phase I and IIa) and Advanced Therapeutic Medicinal Products (ATMPs) studies. Since its introduction across the UK in 2023 it has helped speed up commercial research set up times, making the UK a more attractive place for commercial organisations to undertake research studies, ensuring UK patients have e...
Training and Events
The Network try to ensure a presence at relevant events across the country and share training opportunities of interest to the stroke research community. For any enquiries regarding training, please contact Karen McBurnie at karen.mcburnie2@nhs.scot. The Network is not responsible for the content on external pages.
Regional Working
The major research Boards across Scotland - North (NHS Grampian), East (NHS Tayside), South (NHS Lothian) and West (NHS Greater Glasgow & Clyde) - play a leading role in supporting the delivery of research and R&D Directors from these Health Boards form part of the NRS Strategy Board providing regional expertise and an in-depth view of research activity across Scotland. Together with the Chief Scientist Office (CSO) they work to develop common, simplified systems to support bot...
Student Information & Work Experience
NHS Greater Glasgow & Clyde (NHS GGC) are at the forefront of healthcare innovation, and the opening of the new Queen Elizabeth University Hospital (QEUH) has established the largest hospital campus in Europe. The integration and collaboration of the Health Service and Universities in NHS GGC provides a robust infrastructure supporting an active clinical research community and enthusiastic research staff. The network of Clinical Research Facilities in NHS GGC supports a busy...
Professor Susan Shenkin
Get Involved
High quality research, good recruitment and improved health outcomes for children, depend on listening to the voices of children and young people, as well as their families and carers. Children, families, carers and members of the public can get involved by voluntarily taking part in research, or by helping to shape research. NRS Children's has set up a Young Persons’ Group to act as advocates for young people in clinical trials in Scotland. Role of the YPG:
News and opportunities
Providing information on the latest news from across the musculoskeletal research community and the clinical research community in Scotland more generally News from NHS Research Scotland The latest news from NHS Research Scotland
NHS Research Scotland Mental Health Annual Scientific Meeting 2024
'Balancing Viewpoints: Rights, Data and Empowerment' This year we are hosting a hybrid event, with the opportunity to join us in person at the venue or virtually online. Anyone with an interest or involved with mental health research in Scotland can attend. We are delighted to announce that Professor Dame Anna Dominiczak (Chief Scientist, Health) will be joining us to give the opening address. Please note, this event has now sold out. You can
